(Reuters) - The U.S. Food and Drug Administration said on Tuesday it required short-acting opioid pain medications to carry a boxed warning about the serious risks of misuse, abuse, addiction, overdose and death.
http://ift.tt/xePdMM
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire